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Can serum progesterone be used to decide 
altrenogest supplementation discontinuation in 
problem pregnancies in mares?
Introduction
Altrenogest is commonly used as a treatment as well as a prevention in high-risk pregnancy. 
Administration is sometimes initiated as early as 2 days post-ovulation and is commonly continued until 
day 100-120. However, this long administration of altrenogest is not always necessary. The aim of this 
study was to determine if altrenogest interfered with progesterone (P4) assay and if timing of altrenogest
administration discontinuation could be based on blood concentration of P4.
Results
• Altrenogest, in both groups:
• Day 0 was used as a control : concentration almost 
not detectable
• Day 6 > Day 0 
• Day 18: basal concentrations
• Progesterone:
• Anoestrus group: basal concentration (<0.4 ng/ml) 
all through the experiment
• Diestrus group: 
• Highly variable concentrations from one mare to 
the other (eg 4.2 to 28 ng/ml at day 6)
• T6 >T12.
Conclusion
Concentration of P4 assayed by RIA seems to be a reliable method to evaluate the 
functionality of the secondary CL’s in mares supplemented with altrenogest. However 
further studies are necessary to investigate the potential effect of long-term 
altrenogest administration on endogenous P4.
Discussion
• P4 remained basal throughout all the experiment in the 
anoestrus group even with altrenogest supplementation. 
Therefore,  a cross-reaction between assays of both 
molecules was not observed.
• In the diestrus group, the evolution of P4 concentrations 
was as expected in a non supplemented mare. The 
administration of altrenogest did not have any effect in the 
concentration of P4 during the study period.
•As expected (half-life of 10.7h +/- 4.3) altrenogest was 




• 7 mares in diestrus during the breeding season. 
• 7 mares in  seasonal anoestrus out of the breeding season. 
Experimental design: 
• Mares received 0.04 mg/kg of Regumate PO once a day
for 12 days, starting:
• 2 days after ovulation for mares in diestrus
• At any time for mares in anoestrus. 
• Blood samples : 
• Day 0 (1st day of treatment)
• Day 6
• Day 12 
• Day 18 (6 days after treatment discontinuation)
• Laboratory analysis:
• P4  Radioimmunoassay (RIA)
• Altrenogest  Liquid Chromatography-Mass Spectrometry
Statistical methods:
• Differences between sampling were determined by Friedman 
non parametric test.
• Significance was established at p<0.05. 
